You are here

  • Home
  • Archive
  • Volume 65, Issue 1
  • Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

Article info

Article menu
Download PDFPDF
Concise reports
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

Authors

  1. Correspondence to:
    Dr S Sato
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Science, 1–7–1 Sakamoto, Nagasaki, 852–8501, Japan; s-sato{at}net.nagasaki-u.ac.jp
View Full Text

Citation

Yanaba K, Komura K, Kodera M, et al
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
Annals of the Rheumatic Diseases 2006;65:124-126.

Publication history

  • Accepted May 15, 2005
  • First published December 12, 2005.
Online issue publication 
April 10, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2006 by Annals of the Rheumatic Diseases